Valuation (14%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.35 | 42.94 |
PEG Ratio (TTM) | -0.01 | 4.58 |
P/S Ratio (TTM) | 1.93 | 8.29 |
P/B Ratio (TTM) | 4.79 | 6.29 |
P/FCF Ratio (TTM) | -1.25 | 12.17 |
Price to 5YR AVG Earnings Ratio | -0.02 | 115.30 |
Price to 5YR AVG FCF Ratio | -0.51 | -18.58 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -61.24% | 1.39% |
ROE (TTM) | -816.22% | 10.32% |
Net Profit Margin (TTM) | -512.16% | -20.63% |
ROIC 5YR AVG | -227.07% | 10.64% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -16.85% | -14,981,077.34% | -8,988,689.01% |
Revenue | -29.92% | N/A | N/A |
Net Income | 15.40% | -6,004,697.91% | -3,602,864.64% |
Cash Flow | 17.25% | -139,616.73% | -83,776.92% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.56 | 1.29 |
Quick Ratio (TTM) | 0.29 | 1.08 |
D/E Ratio (TTM) | 0.64 | 1.46 |
Interest Coverage (TTM) | N/A | 0.38 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 1.72 |
LTL to 5YR AVG FCF | -0.52 | -18.37 |
Shares Outstanding Growth 5YR AVG | 115.72% | 3.04% |